Editorial Commentary
Transcatheter therapies have not forgotten the tricuspid valve

https://doi.org/10.1016/j.jtcvs.2018.04.113Get rights and content
Under an Elsevier user license
open archive

Cited by (0)

Disclosures: T.R.: Consultant: Medtronic. Intellectual property: co-inventor on patents, assigned to the National Institutes of Health, for transcatheter devices to treat TR. V.H.T.: Advisor/Research: Edwards Lifesciences, Abbott Vascular, Claret Medical, Boston Scientific, Gore Vascular, and JenaValve.